US 8414876
Methods of using IL-1 antagonists to treat autoinflammatory disease
granted A61KA61K38/00A61K38/177
Quick answer
US patent 8414876 (Methods of using IL-1 antagonists to treat autoinflammatory disease) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Apr 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K38/00, A61K38/177, A61K45/06, A61P